Latest Breaking News On - Concept medicals fourth ide approval for the magictouch sirolimus coated balloon is granted treatment of superficial femoral artery disease sfa - Page 1 : comparemela.com
PRNewswire, Tampa (Florida) [US], May 29: The US FDA, on the 24th of May 2023, granted an Investigational Device Exemption (IDE) approval for Sirolimus Coated Balloon (SCB) for the treatment of Superficial Femoral Arteries (SFA).